Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary E LaMarca

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Genetics and Metabolism|April 28, 2007
Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson diseaseShira G Ziegler, Michael J Eblan, Usha Gutti, et al.
Molecular Genetics and Metabolism|December 17, 2009
In silico and functional studies of the regulation of the glucocerebrosidase geneYotam N Blech-Hermoni, Shira G Ziegler, Kathleen S Hruska, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher diseaseWei Zheng, Janak Padia, Daniel J Urban, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Genetics and Metabolism|April 28, 2007
Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson diseaseShira G Ziegler, Michael J Eblan, Usha Gutti, et al.
Molecular Genetics and Metabolism|December 17, 2009
In silico and functional studies of the regulation of the glucocerebrosidase geneYotam N Blech-Hermoni, Shira G Ziegler, Kathleen S Hruska, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher diseaseWei Zheng, Janak Padia, Daniel J Urban, et al.
Pageof 2